TROG 04.02 - Cervical - FIGO Stage & Tumour Volume - TROG Cancer Research

Read Angelo's story about taking part in our kidney cancer trial

Sign up now to join our Km's for Cancer Research Challenge in October

Submit your trial idea by 6 October for our 2026 Concept Development Workshop

Abstract submissions for TROG 2027 ASM close 9 October: Submit your abstract now.

TROG ASM Attendance Grants: Applications now open

By w.paterson
15 August, 2021
0 Comments

Prospective Study to Determine the Relationships Between Survival and FIGO Stage, Tumour Volume and Corpus Invasion in Cervical Cancer.

Primary Sponsor

Trans-Tasman Radiation Oncology Group (TROG)

Clinical Trial Registration

Registration Link

Related Post

26 September, 2026

Trial finds radiation therapy halves risk of brain tumour recurrence after surgery

LATEST NEWS: 26 September 2026 Giving radiotherapy after surgery

17 September, 2026

Meet the TROG Quality Assurance team

TROG UPDATES: 17 September 2026 Our Quality Assurance team